April 22, 2025
Medical Affairs Is Stepping Into the Future
The energy was palpable at the 2025 Medical Affairs Professional Society (MAPS) Global Annual Meeting. Conversations…
All Categories,Decision-Making and Process,Strategy and Planning
October 21, 2024
The Power of Key Business Questions
In our biopharma world, we frequently hear the term “Key Business Questions (KBQs).” And while it’s often thrown around…
All Categories,Decision-Making and Process,Strategy and Planning
September 24, 2024
The Underappreciated Value of New Product Planning
The value of New Product Planning (NPP) is often overlooked, but it plays a crucial role in the success of drug…
All Categories,Decision-Making and Process,Strategy and Planning
August 21, 2024
Biopharma Annual Planning Success: Close Your Rings Year-Round
How do we think about biopharma annual planning differently? The analogy we will draw on is fitness trackers and…
All Categories,Decision-Making and Process,Strategy and Planning
July 22, 2024
The Power of Target Product Profiles: Three Case Studies
In the biopharma industry, the Target Product Profile (TPP) is a critical tool for guiding the development and…
All Categories,Decision-Making and Process,Strategy and Planning
June 25, 2024
Unlocking Success: The Power of Target Product Profiles
In the ever-evolving biopharma landscape, success hinges not just on innovation but also on a clear roadmap guiding…
All Categories,Decision-Making and Process,Strategy and Planning
April 23, 2024
Governance: The Glue to a Successful Launch
At the core of every successful launch lies a meticulously crafted plan, a robust governance structure, and expert…
All Categories,Decision-Making and Process,Strategy and Planning
March 26, 2024
Your Biopharma Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a commodity with limited breadth or depth for…
All Categories,Decision-Making and Process,Strategy and Planning
January 24, 2024
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country…
All Categories,Decision-Making and Process,Strategy and Planning









